Results 221 to 230 of about 1,300,736 (395)
PARTIAL AMINO ACID SEQUENCE OF HLA-A9 ANTIGEN PURIFIED WITH A SPECIFIC XENOANTISERM
NULL AUTHOR_ID
openalex +1 more source
Isolation of a cDNA clone for the human HLA-DR antigen alpha chain by using a synthetic oligonucleotide as a hybridization probe. [PDF]
D Stetler+7 more
openalex +1 more source
HLA ANTIGENIC DIFFERENCE BETWEEN LYMPHOCYTES AND GRANULOCYTES
Tadashi Sowa+4 more
openalex +2 more sources
Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. [PDF]
M Tsujisaki+5 more
openalex +1 more source
HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours
Jir̂í Bártek+5 more
openalex +2 more sources
Single‐Cell Transcriptomic Analysis of the Immune Response to COVID‐19 and Tuberculosis Coinfection
Understanding the immunological basis for severe outcomes in COVID‐19/Tuberculosis coinfection is critical. Our single‐cell analysis identifies key drivers: profound lymphocyte loss through combined apoptosis and altered trafficking, excessive S100 protein‐mediated inflammation contributing to cytokine storms, and systemic immune dysfunction ...
Yi Wang+20 more
wiley +1 more source
Identification of potential antigenic peptides of Brucella through proteome and peptidome
Based on proteomics and peptidomics, we identified 35 peptides from the Brucella proteome, which have the ability to bind MHC molecules and have the potential to be used in vaccine design. In addition, we also found four Brucella proteins containing the identified MHC‐I and MHC‐II binding peptides, which may be good candidate targets for designing ...
Meijuan Pei+10 more
wiley +1 more source
Summary: Background: In solid organ transplantation, HLA matching between donor and recipient is associated with superior outcomes. In islet transplantation, an intervention for Type 1 diabetes, HLA matching between donor and recipient is not performed ...
Shareen Forbes+13 more
doaj
J. V. van Rood+5 more
semanticscholar +1 more source
Abstract Mesenchymal stem cells (MSCs) have regenerative capacity and have reported a beneficial effect on the Japanese encephalitis virus (JEV) in an encephalitis model. However, the MSCs do not cross the blood–brain barrier and have other disadvantages limiting their therapeutic utility scope.
Naina Soni+6 more
wiley +1 more source